---
$id: https://graph.org.ai/products/commodity/51361930
$type: Product
source: UNSPSC
code: "51361930"
title: "Barbital sodium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Barbital sodium

**UNSPSC Code**: 51361930
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C8H11N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 275L5M93QS, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-diethyl-, monosodium salt (9ci) but more generally known as barbital sodium, which bears US NIH Compound Identifier 8943. European Medicines Agency schedules Barbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06103MIG. The term BARBITAL SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). Most nations, for tariff and trade purposes, schedule barbital sodium under HS 29335310. As of Q4 2014, BARBITAL SODIUM remains US FDA's Preferred Term for this commodity. Barbital sodium bears US NLM identifiers UMLS ID C0770386 and NCI Concept Code C77627. SMILES: CCC1(C(=O)NC(=O)[N-]C1=O)CC.[NA+].

